Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7709486 CXCR4 antagonists

Patent 7709486 was granted and assigned to Genzyme on May, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genzyme
Genzyme
0
Date Filed
July 29, 2008
0
Date of Patent
May 4, 2010
0
Patent Application Number
12182044
0
Patent Citations Received
‌
US Patent 11987598 E-selectin antagonist compounds, compositions, and methods of use
0
‌
US Patent 11707474 Methods for treating acute myeloid leukemia and related conditions
0
‌
US Patent 11712446 Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
0
‌
US Patent 11780873 Highly potent multimeric e-selectin antagonists
‌
US Patent 11878026 Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
0
Patent Inventor Names
David Earl Bogucki
0
Dominique Schols
0
Eva Maria Boehringer
0
Gary J. Bridger
0
Renato Tony Skerlj
0
Zhongren Wang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7709486
0
Patent Primary Examiner
‌
Brenda L Coleman
0

Find more entities like US Patent 7709486 CXCR4 antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo